Trial: 202201130

A Phase 1/2 Trial of CBL0137 (NSC# 825802, IND# 155843) in Patients with Relapsed or Refractory Solid Tumors including CNS Tumors and Lymphoma

Phase

I/II

Principal Investigator

Hayashi, Robert

Disease Site

Anus; Bones and Joints; Brain and Nervous System; Breast; Cervix; Colon; Esophagus; Eye and Orbit; Hodgkin Lymphoma; Kidney; Larynx; Lip, Oral Cavity and Pharynx; Liver; Lung; Melanoma, Skin; Non-Hodgkin Lymphoma; Pancreas; Prostate; Rectum; Small Intestine; Soft Tissue; Stomach; Thyroid; Urinary Bladder

Learn more about this study at: clinicaltrials.gov